Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CP 316,819 is an inhibitor of glycogen phosphorylase A (IC50 = 40 nM for the human liver enzyme).1 It increases intracellular glycogen content in astrocytes when used at a concentration of 10 µM.2 CP 316,819 (250 mg/kg) increases brain glycogen content but does not prevent depletion of glycogen stores in a rat model of brain ischemia induced by decapitation. It also prolongs neuronal function and decreases neurodegeneration in a rat model of insulin-induced hypoglycemia.
WARNING This product is not for human or veterinary use.
1. Establishment of correlation between in vitro enzyme binding potency and in vivo pharmacological activity: Application to liver glycogen phosphorylase a inhibitors. J. Pharmacol. Exp. Ther. 317(3), 1230-1237 (2006).
2. Astrocyte glycogen sustains neuronal activity during hypoglycemia: Studies with the glycogen phosphorylase inhibitor CP-